The A1 mutation decreases antisense transcriptional activity of the LTR in OVK cells. by Thomas Joris (13224720)

S100a9 Knockdown Decreases the Memory Impairment and the Neuropathology in Tg2576 Mice, AD Animal Model by Tae-Young Ha (254769)

Subjects:

miR-100 decreases tumor size. by Bahauddeen M. Alrfaei (484859)

RA increases S100β+ and decreases peripherin+ cell prevalence while EDN3 decreases S100β+ cell prevalence. by Jonathan M. Gisser (456149)

“…(A) The proportion of S100β+ cells was enriched by RA and decreased in response to EDN3 (B) RA increased, and EDN3 decreased the fraction of proliferating S100β+ cells. …”

S100A9 Knockout Decreases the Memory Impairment and Neuropathology in Crossbreed Mice of Tg2576 and S100A9 Knockout Mice Model by Hee Jin Kim (469168)

Subjects:

(R)-albuterol decreases cytokine mRNA levels in activated T cells by Marcela A Ferrada (41716)

“…</p><p></p> (R)-albuterol, (S)-albuterol or racemic albuterol (R + S) at a dose (10M) were added to T (EL-4) cells pre-activated with mitogens Concanavalin A (Con A, 5 μg/ml) and phorbol myristate acetate (PMA, 100 ng/ml) (CP). …”

Rhodomyrtone dose dependently decreases production of <i>CXCL1</i>, <i>IL-36G</i>, <i>IL-36RN</i>, <i>MMP-13</i>, <i>S100A7</i>, <i>S100A8</i>, and <i>S100A12</i> transcripts by IL-17A/TNF-α-stimulated primary human keratinocytes. by Julalak Chorachoo (5855852)

S100A7 downregulation decreases osteolytic lesions <i>in vivo.</i> by Vikram Paruchuri (87721)

UGGT activity decreases in <i>uggt-1(RNAi)</i> worms but no decrease was observed in <i>uggt-2 (RNAi)</i> worms. by Lucila I. Buzzi (198284)

RUE decreases expression of inflammatory cytokines through MAPK-NF-κB pathway. by Jeong Hoon Pan (844624)

GIRK2^AgRP-KO mice show decreased EE associated with BAT dysfunction and decreased sympathetic activity. by Youjin Oh (3308670)

FASN inhibitors result in decreased ΔΨm and increased superoxide production in melan-a cells. by Franco A. Rossato (588513)

FASN inhibitors result in decreased ΔΨm and increased superoxide production in melan-a cells. by Franco A. Rossato (588513)

Loss of <i>SLC4A11</i> expression in hCEnC leads to decreased cell barrier function. by Doug D. Chung (3611387)

Means and 95% confidence interval (CI) of all costs, benefits, and the difference in net benefits from the probabilistic reference case given in 2019 USD for 3 years for a 100-cow... by Marlena Waldbauer (18291223)

R848 mediated RANTES, but not TNF-α production, is significantly decreased in TRAM^−/− iBMDMs. by Enda Shevlin (628477)

Excitotoxicity-induced decrease in GAD65/67 activity. by Márcio S. Baptista (365618)

Vinpocetine inhibits carrageenan-induced decrease in antioxidant capacity. by Kenji W. Ruiz-Miyazawa (714809)

Stx2 and SubAB decrease HGEC viability. by María M. Amaral (439445)

The decrease or inhibition of Hsp90 induced REST degradation. by Raúl Orozco-Díaz (7067624)

“…<p>(A) Effect of Hsp90α ASO on cell viability. Differentiated SH-SY5Y cells were transfected with different concentrations of Hsp90α ASO. …”